Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Recommendations
Anaplan price target raised to $57 from $51 at Goldman Sachs » 07:13
06/24/20
06/24
07:13
06/24/20
07:13
PLAN

Anaplan

$47.09 /

-0.66 (-1.38%)

Goldman Sachs analyst…

Goldman Sachs analyst Heather Bellini raised the firm's price target on Anaplan to $57 from $51 and keeps a Buy rating on the shares. The analyst increased price targets across her Software and Select Internet coverage universe to reflect higher peer multiples, lower interest rates, and reduced equity risk premiums. Following a 30% contraction in the average enterprise value to sales multiples from the February peak, valuations across software have expanded 75% from mid-March troughs, surpassing July 2019 highs, Bellini tells investors in a research note.

ShowHide Related Items >><<
PLAN Anaplan
$47.09 /

-0.66 (-1.38%)

PLAN Anaplan
$47.09 /

-0.66 (-1.38%)

05/27/20 RBC Capital
Anaplan price target lowered to $51 from $55 at RBC Capital
05/27/20 Deutsche Bank
Anaplan price target raised to $55 from $50 at Deutsche Bank
05/27/20 Mizuho
Anaplan price target raised to $58 from $50 at Mizuho
05/26/20 Piper Sandler
Anaplan price target raised to $51 from $38 at Piper Sandler
PLAN Anaplan
$47.09 /

-0.66 (-1.38%)

PLAN Anaplan
$47.09 /

-0.66 (-1.38%)

PLAN Anaplan
$47.09 /

-0.66 (-1.38%)

Over a month ago
Options
Anaplan call buyer realizes 14% same-day gains » 08:00
05/28/20
05/28
08:00
05/28/20
08:00
PLAN

Anaplan

$45.01 /

-2.1 (-4.46%)

Notable profits for the…

Notable profits for the buyer who lifted the $7.35 offer for 4,245 Anaplan (PLAN) Jan-21 45 calls yesterday at 11:33ET when underlying shares were trading at $43.24. Shares closed at $45.06, and the calls at $8.40 for a mark-to-market profit of 14%, or $445K, on the $3121K outlay.

ShowHide Related Items >><<
PLAN Anaplan
$45.01 /

-2.1 (-4.46%)

PLAN Anaplan
$45.01 /

-2.1 (-4.46%)

05/27/20 RBC Capital
Anaplan price target lowered to $51 from $55 at RBC Capital
05/27/20 Deutsche Bank
Anaplan price target raised to $55 from $50 at Deutsche Bank
05/27/20 Mizuho
Anaplan price target raised to $58 from $50 at Mizuho
05/26/20 Piper Sandler
Anaplan price target raised to $51 from $38 at Piper Sandler
PLAN Anaplan
$45.01 /

-2.1 (-4.46%)

PLAN Anaplan
$45.01 /

-2.1 (-4.46%)

PLAN Anaplan
$45.01 /

-2.1 (-4.46%)

Recommendations
Anaplan price target lowered to $51 from $55 at RBC Capital » 09:20
05/27/20
05/27
09:20
05/27/20
09:20
PLAN

Anaplan

$47.11 /

-3.96 (-7.75%)

RBC Capital analyst Alex…

RBC Capital analyst Alex Zukin lowered the firm's price target on Anaplan to $51 from $55 but keeps an Outperform rating on the shares. The company posted "mixed" Q1 results with revenue and profitability exceeding expectations and billings missing, the analyst tells investors in a research note, noting that the management's guidance was also shy of consensus. Zukin adds that near-term dynamics for Anaplan remain challenging due to the macro backdrop, but the management's Q2 guidance and his second-half estimates are also "highly conservative."

ShowHide Related Items >><<
PLAN Anaplan
$47.11 /

-3.96 (-7.75%)

PLAN Anaplan
$47.11 /

-3.96 (-7.75%)

05/27/20 Deutsche Bank
Anaplan price target raised to $55 from $50 at Deutsche Bank
05/27/20 Mizuho
Anaplan price target raised to $58 from $50 at Mizuho
05/26/20 Piper Sandler
Anaplan price target raised to $51 from $38 at Piper Sandler
05/26/20 Piper Sandler
Piper Sandler would be buyers on Anaplan weakness following earnings
PLAN Anaplan
$47.11 /

-3.96 (-7.75%)

PLAN Anaplan
$47.11 /

-3.96 (-7.75%)

PLAN Anaplan
$47.11 /

-3.96 (-7.75%)

Recommendations
Anaplan price target raised to $55 from $50 at Deutsche Bank » 07:36
05/27/20
05/27
07:36
05/27/20
07:36
PLAN

Anaplan

$47.11 /

-3.96 (-7.75%)

Deutsche Bank analyst…

Deutsche Bank analyst Taylor McGinnis raised the firm's price target on Anaplan to $55 from $50 and keeps a Buy rating on the shares. Against a backdrop of mixed investor sentiment, Anaplan delivered Q1 results that fell short of expectations, McGinnis tells investors in a research note. However, the Q2 billings guide was an unexpected surprise and helps to provide some near-term visibility, adds the analyst. McGinnis believes that Anaplan is well positioned to outperform upon an IT budget recovery given its "strengthened value proposition in this environment."

ShowHide Related Items >><<
PLAN Anaplan
$47.11 /

-3.96 (-7.75%)

PLAN Anaplan
$47.11 /

-3.96 (-7.75%)

05/27/20 Mizuho
Anaplan price target raised to $58 from $50 at Mizuho
05/26/20 Piper Sandler
Anaplan price target raised to $51 from $38 at Piper Sandler
05/26/20 Piper Sandler
Piper Sandler would be buyers on Anaplan weakness following earnings
05/26/20 Goldman Sachs
Anaplan should benefit as macro situation improves, says Goldman Sachs
PLAN Anaplan
$47.11 /

-3.96 (-7.75%)

PLAN Anaplan
$47.11 /

-3.96 (-7.75%)

PLAN Anaplan
$47.11 /

-3.96 (-7.75%)

Recommendations
Anaplan price target raised to $58 from $50 at Mizuho » 06:48
05/27/20
05/27
06:48
05/27/20
06:48
PLAN

Anaplan

$47.11 /

-3.96 (-7.75%)

Mizuho analyst Siti…

Mizuho analyst Siti Panigrahi raised the firm's price target on Anaplan to $58 from $50 and reiterates a Buy rating on the shares. Anaplan yesterday reported mixed Q1 results and lowered Q2 guidance while rescinding its fiscal 2021 guidance, Panigrahi tells investors in a research note. Despite the ongoing short-term headwinds from COVID-19, the company's sales reorganization continues to stabilize and management's commentary validates the thesis that the need for robust planning tools has been heightened, says the analyst. Panigrahi believes Anaplan is well positioned to capitalize on the opportunity "once the normalcy returns."

ShowHide Related Items >><<
PLAN Anaplan
$47.11 /

-3.96 (-7.75%)

PLAN Anaplan
$47.11 /

-3.96 (-7.75%)

05/26/20 Piper Sandler
Anaplan price target raised to $51 from $38 at Piper Sandler
05/26/20 Piper Sandler
Piper Sandler would be buyers on Anaplan weakness following earnings
05/26/20 Goldman Sachs
Anaplan should benefit as macro situation improves, says Goldman Sachs
05/26/20 Rosenblatt
Rosenblatt says Anaplan reliance on large projects 'clearly impacting' business
PLAN Anaplan
$47.11 /

-3.96 (-7.75%)

PLAN Anaplan
$47.11 /

-3.96 (-7.75%)

PLAN Anaplan
$47.11 /

-3.96 (-7.75%)

On The Fly
Fly Intel: Wall Street's top stories for Tuesday » 16:34
05/26/20
05/26
16:34
05/26/20
16:34
MRK

Merck

$77.26 /

+0.89 (+1.17%)

, NVAX

Novavax

$48.24 /

+2.1 (+4.55%)

, REGN

Regeneron

$545.22 /

-24.72 (-4.34%)

, SNY

Sanofi

$47.27 /

-0.04 (-0.08%)

, BMRN

BioMarin

$103.55 /

+6.05 (+6.21%)

, ARGX

Argenx

$212.33 /

+54.07 (+34.17%)

, PLAN

Anaplan

$47.11 /

-3.96 (-7.75%)

, HTZ

Hertz

$0.59 /

-2.2499 (-79.22%)

, UAL

United Airlines

$29.54 /

+4.145 (+16.32%)

, AAL

American Airlines

$11.14 /

+1.425 (+14.67%)

, RCL

Royal Caribbean

$49.55 /

+6.37 (+14.75%)

, NCLH

Norwegian Cruise Line

$16.03 /

+2.14 (+15.41%)

Stocks rallied amid a…

Open Full Text

ShowHide Related Items >><<
UAL United Airlines
$29.54 /

+4.145 (+16.32%)

SNY Sanofi
$47.27 /

-0.04 (-0.08%)

REGN Regeneron
$545.22 /

-24.72 (-4.34%)

RCL Royal Caribbean
$49.55 /

+6.37 (+14.75%)

PLAN Anaplan
$47.11 /

-3.96 (-7.75%)

NVAX Novavax
$48.24 /

+2.1 (+4.55%)

NCLH Norwegian Cruise Line
$16.03 /

+2.14 (+15.41%)

MRK Merck
$77.26 /

+0.89 (+1.17%)

HTZ Hertz
$0.59 /

-2.2499 (-79.22%)

BMRN BioMarin
$103.55 /

+6.05 (+6.21%)

ARGX Argenx
$212.33 /

+54.07 (+34.17%)

AAL American Airlines
$11.14 /

+1.425 (+14.67%)

MRK Merck
$77.26 /

+0.89 (+1.17%)

05/27/20 Alliance Global Partners
PDS Biotechnology initiated with a Buy at Alliance Global Partners
05/20/20 JonesTrading
Merck collaboration positions Surface Oncology well, says JonesTrading
04/27/20 SVB Leerink
Clovis downgraded to Underperform at SVB Leerink as prostate opportunity fades
04/06/20 Raymond James
NGM Biopharmaceuticals initiated with a Strong Buy at Raymond James
NVAX Novavax
$48.24 /

+2.1 (+4.55%)

05/26/20 B. Riley FBR
Novavax has become a leading COVID vaccine candidate, says B. Riley FBR
05/18/20 B. Riley FBR
Novavax price target raised to $53 from $43 at B. Riley FBR
05/14/20 Ladenburg
Novavax price target raised to $50 from $38 at Ladenburg
05/12/20 B. Riley FBR
Novavax price target raised to $43 from $29 at B. Riley FBR
REGN Regeneron
$545.22 /

-24.72 (-4.34%)

05/27/20 Citi
BioMarin a good takeout candidate, but not by Sanofi, says Citi
05/26/20
Fly Intel: Top five analyst upgrades
05/26/20 RBC Capital
BioMarin among Sanofi's most intriguing potential targets, says RBC Capital
05/26/20 Piper Sandler
Piper remains buyer of Regeneron, ups target to $630 on buyback accretion
SNY Sanofi
$47.27 /

-0.04 (-0.08%)

05/26/20 UBS
Sanofi price target lowered to EUR 101 from EUR 103 at UBS
05/26/20 SVB Leerink
Sanofi overhang removed, Regeneron capital structure improving, says SVB Leerink
BMRN BioMarin
$103.55 /

+6.05 (+6.21%)

05/22/20 Jefferies
Jefferies adds six names to Franchise Picks list, including BioMarin and TJX
05/08/20 Canaccord
BioMarin price target raised to $119 from $108 at Canaccord
ARGX Argenx
$212.33 /

+54.07 (+34.17%)

05/27/20 SunTrust
Argenx price target raised to $240 from $192 at SunTrust
05/27/20 Guggenheim
Argenx price target raised to $225 from $201 at Guggenheim
05/27/20 Baird
Argenx price target raised to $235 from $170 at Baird
05/26/20 BMO Capital
BMO Capital still sees favorable risk/reward in Alexion following Argenx news
PLAN Anaplan
$47.11 /

-3.96 (-7.75%)

05/27/20 Deutsche Bank
Anaplan price target raised to $55 from $50 at Deutsche Bank
05/27/20 Mizuho
Anaplan price target raised to $58 from $50 at Mizuho
05/26/20 Piper Sandler
Anaplan price target raised to $51 from $38 at Piper Sandler
05/26/20 Piper Sandler
Piper Sandler would be buyers on Anaplan weakness following earnings
HTZ Hertz
$0.59 /

-2.2499 (-79.22%)

05/05/20 Morgan Stanley
2020 may not be quite as bad as feared for used cars, says Morgan Stanley
04/27/20
Fly Intel: Top five analyst downgrades
04/27/20 Barclays
Barclays downgrades Hertz to Underweight on risk of capital call
04/27/20 Barclays
Hertz downgraded to Underweight from Equal Weight at Barclays
UAL United Airlines
$29.54 /

+4.145 (+16.32%)

05/26/20 Citi
Lufthansa bailout 'marginally positive' for United Airlines,says Citi
05/19/20 Goldman Sachs
Southwest, United seeing modest improvements in demand, says Goldman Sachs
05/04/20 Barclays
Barclays downgrades U.S. Airlines sector along with American and Delta
05/04/20 Barclays
United Airlines price target lowered to $40 from $60 at Barclays
AAL American Airlines
$11.14 /

+1.425 (+14.67%)

05/04/20 Barclays
American Airlines downgraded to Underweight from Equal Weight at Barclays
05/01/20 Evercore ISI
American Airlines price target lowered to $1 from $10 at Evercore ISI
04/27/20 Citi
American Airlines price target lowered to $10 from $13 at Citi
RCL Royal Caribbean
$49.55 /

+6.37 (+14.75%)

05/21/20
Fly Intel: Top five analyst initiations
05/21/20 JPMorgan
Royal Caribbean price target lowered to $50 from $55 at JPMorgan
05/21/20 Deutsche Bank
Royal Caribbean price target lowered to $36 from $38 at Deutsche Bank
05/21/20 Credit Suisse
Cruise stocks initiated at Credit Suisse, sees unique vacation opportunity
NCLH Norwegian Cruise Line
$16.03 /

+2.14 (+15.41%)

05/21/20 Credit Suisse
Norwegian Cruise Line initiated with an Outperform at Credit Suisse
05/18/20 SunTrust
Norwegian Cruise Line price target lowered to $14 from $45 at SunTrust
UAL United Airlines
$29.54 /

+4.145 (+16.32%)

SNY Sanofi
$47.27 /

-0.04 (-0.08%)

REGN Regeneron
$545.22 /

-24.72 (-4.34%)

RCL Royal Caribbean
$49.55 /

+6.37 (+14.75%)

PLAN Anaplan
$47.11 /

-3.96 (-7.75%)

NVAX Novavax
$48.24 /

+2.1 (+4.55%)

NCLH Norwegian Cruise Line
$16.03 /

+2.14 (+15.41%)

MRK Merck
$77.26 /

+0.89 (+1.17%)

HTZ Hertz
$0.59 /

-2.2499 (-79.22%)

BMRN BioMarin
$103.55 /

+6.05 (+6.21%)

AAL American Airlines
$11.14 /

+1.425 (+14.67%)

  • 28
    May
  • 27
    May
UAL United Airlines
$29.54 /

+4.145 (+16.32%)

SNY Sanofi
$47.27 /

-0.04 (-0.08%)

REGN Regeneron
$545.22 /

-24.72 (-4.34%)

RCL Royal Caribbean
$49.55 /

+6.37 (+14.75%)

NVAX Novavax
$48.24 /

+2.1 (+4.55%)

NCLH Norwegian Cruise Line
$16.03 /

+2.14 (+15.41%)

MRK Merck
$77.26 /

+0.89 (+1.17%)

HTZ Hertz
$0.59 /

-2.2499 (-79.22%)

AAL American Airlines
$11.14 /

+1.425 (+14.67%)

UAL United Airlines
$29.54 /

+4.145 (+16.32%)

REGN Regeneron
$545.22 /

-24.72 (-4.34%)

RCL Royal Caribbean
$49.55 /

+6.37 (+14.75%)

PLAN Anaplan
$47.11 /

-3.96 (-7.75%)

NVAX Novavax
$48.24 /

+2.1 (+4.55%)

NCLH Norwegian Cruise Line
$16.03 /

+2.14 (+15.41%)

MRK Merck
$77.26 /

+0.89 (+1.17%)

HTZ Hertz
$0.59 /

-2.2499 (-79.22%)

BMRN BioMarin
$103.55 /

+6.05 (+6.21%)

ARGX Argenx
$212.33 /

+54.07 (+34.17%)

AAL American Airlines
$11.14 /

+1.425 (+14.67%)

UAL United Airlines
$29.54 /

+4.145 (+16.32%)

SNY Sanofi
$47.27 /

-0.04 (-0.08%)

REGN Regeneron
$545.22 /

-24.72 (-4.34%)

RCL Royal Caribbean
$49.55 /

+6.37 (+14.75%)

PLAN Anaplan
$47.11 /

-3.96 (-7.75%)

NVAX Novavax
$48.24 /

+2.1 (+4.55%)

NCLH Norwegian Cruise Line
$16.03 /

+2.14 (+15.41%)

MRK Merck
$77.26 /

+0.89 (+1.17%)

HTZ Hertz
$0.59 /

-2.2499 (-79.22%)

BMRN BioMarin
$103.55 /

+6.05 (+6.21%)

AAL American Airlines
$11.14 /

+1.425 (+14.67%)

Recommendations
Anaplan price target raised to $51 from $38 at Piper Sandler » 15:14
05/26/20
05/26
15:14
05/26/20
15:14
PLAN

Anaplan

$47.75 /

-3.32 (-6.50%)

As previously reported,…

As previously reported, Piper Sandler analyst Brent Bracelin raised the firm's price target on Anaplan to $51 from $38 and keeps an Overweight rating on the shares. The analyst feels that while procurement delays and some exposure to heavily impacted industries may cause "more near term lumpiness," the company brings "differentiated technology to uniquely address large enterprise problem sets." He raised his price target on shares to factor in a "better than feared billings outlook and promise of strong secular tailwinds driving an acceleration in growth next year." Bracelin said he would be a buyer of Anaplan shares amid the weakness in the stock following the company's quarterly report, citing the importance of real-time planning.

ShowHide Related Items >><<
PLAN Anaplan
$47.75 /

-3.32 (-6.50%)

PLAN Anaplan
$47.75 /

-3.32 (-6.50%)

05/26/20 Piper Sandler
Piper Sandler would be buyers on Anaplan weakness following earnings
05/26/20 Goldman Sachs
Anaplan should benefit as macro situation improves, says Goldman Sachs
05/26/20 Rosenblatt
Rosenblatt says Anaplan reliance on large projects 'clearly impacting' business
05/21/20 RBC Capital
Anaplan price target raised to $55 from $51 at RBC Capital
PLAN Anaplan
$47.75 /

-3.32 (-6.50%)

PLAN Anaplan
$47.75 /

-3.32 (-6.50%)

PLAN Anaplan
$47.75 /

-3.32 (-6.50%)

Recommendations
Piper Sandler would be buyers on Anaplan weakness following earnings » 15:02
05/26/20
05/26
15:02
05/26/20
15:02
PLAN

Anaplan

$47.42 /

-3.65 (-7.15%)

Piper Sandler analyst…

Piper Sandler analyst Brent Bracelin said he would be a buyer of Anaplan shares amid the weakness in the stock following the company's quarterly report, citing the importance of real-time planning. Bracelin has an Overweight rating on Anaplan with a $51 price target.

ShowHide Related Items >><<
PLAN Anaplan
$47.42 /

-3.65 (-7.15%)

PLAN Anaplan
$47.42 /

-3.65 (-7.15%)

05/26/20 Goldman Sachs
Anaplan should benefit as macro situation improves, says Goldman Sachs
05/26/20 Rosenblatt
Rosenblatt says Anaplan reliance on large projects 'clearly impacting' business
05/21/20 RBC Capital
Anaplan price target raised to $55 from $51 at RBC Capital
05/20/20 Mizuho
Mizuho boosts Anaplan target to $50, makes top pick into Software earnings
PLAN Anaplan
$47.42 /

-3.65 (-7.15%)

PLAN Anaplan
$47.42 /

-3.65 (-7.15%)

PLAN Anaplan
$47.42 /

-3.65 (-7.15%)

Recommendations
Anaplan should benefit as macro situation improves, says Goldman Sachs » 14:55
05/26/20
05/26
14:55
05/26/20
14:55
PLAN

Anaplan

$47.88 /

-3.19 (-6.25%)

Goldman Sachs analyst…

Goldman Sachs analyst Heather Bellini noted how disruptions in the quarter from COVID-19 weighed on Anaplan's new business, calculated billings and remaining performance obligations as customers delayed budgeting decisions. While management withdrew FY21 guidance and there may be some near-term impact from COVID-19, she expects Anaplan will benefit as the macro situation improves and enterprise planning becomes a more strategic priority, Bellini tells investors. She maintains a Buy rating and $51 price target on Anaplan shares, which are down $3.41, or 6.7%, to $47.65 in afternoon trading.

ShowHide Related Items >><<
PLAN Anaplan
$47.88 /

-3.19 (-6.25%)

PLAN Anaplan
$47.88 /

-3.19 (-6.25%)

05/26/20 Rosenblatt
Rosenblatt says Anaplan reliance on large projects 'clearly impacting' business
05/21/20 RBC Capital
Anaplan price target raised to $55 from $51 at RBC Capital
05/20/20 Mizuho
Mizuho boosts Anaplan target to $50, makes top pick into Software earnings
05/20/20 Wells Fargo
Wells Fargo downgrades Anaplan on 'more difficult near-term setup'
PLAN Anaplan
$47.88 /

-3.19 (-6.25%)

PLAN Anaplan
$47.88 /

-3.19 (-6.25%)

PLAN Anaplan
$47.88 /

-3.19 (-6.25%)

On The Fly
Fly Insider: Arconic, Allakos among week's notable insider trades » 13:16
05/26/20
05/26
13:16
05/26/20
13:16
ARNC

Arconic

$13.30 /

+0.41 (+3.18%)

, CLPR

Clipper Realty

$7.26 /

+0.51 (+7.56%)

, SYY

Sysco

$55.12 /

+3.35 (+6.47%)

, GDOT

Green Dot

$37.88 /

+0.08 (+0.21%)

, LAZY

Lazydays

$6.42 /

+0.44 (+7.36%)

, ALRM

Alarm.com

$48.73 /

+2.39 (+5.16%)

, AMK

AssetMark Financial

$25.40 /

-1.3 (-4.87%)

, AMZN

Amazon.com

$2,435.18 /

-0.72 (-0.03%)

, ALLK

Allakos

$71.94 /

-4.84 (-6.30%)

, PLAN

Anaplan

$47.73 /

-3.34 (-6.54%)

Welcome to "Fly Insider,"…

Open Full Text

ShowHide Related Items >><<
SYY Sysco
$55.12 /

+3.35 (+6.47%)

PLAN Anaplan
$47.73 /

-3.34 (-6.54%)

LAZY Lazydays
$6.42 /

+0.44 (+7.36%)

GDOT Green Dot
$37.88 /

+0.08 (+0.21%)

CLPR Clipper Realty
$7.26 /

+0.51 (+7.56%)

ARNC Arconic
$13.30 /

+0.41 (+3.18%)

AMZN Amazon.com
$2,435.18 /

-0.72 (-0.03%)

AMK AssetMark Financial
$25.40 /

-1.3 (-4.87%)

ALRM Alarm.com
$48.73 /

+2.39 (+5.16%)

ALLK Allakos
$71.94 /

-4.84 (-6.30%)

ARNC Arconic
$13.30 /

+0.41 (+3.18%)

05/20/20
Fly Intel: Top five analyst initiations
05/20/20 Credit Suisse
Arconic initiated with an Outperform at Credit Suisse
04/01/20 Cowen
Howmet Aerospace price target lowered to $17 from $23 at Cowen
03/20/20 Barclays
Arconic downgraded to Equal Weight from Overweight at Barclays
CLPR Clipper Realty
$7.26 /

+0.51 (+7.56%)

06/28/19 B. Riley FBR
Clipper Realty selloff on apartment ruling an overreaction, says B. Riley FBR
06/17/19 B. Riley FBR
CatchMark added to Alpha Generator list, Clipper Realty removed, at B. Riley FBR
SYY Sysco
$55.12 /

+3.35 (+6.47%)

04/23/20
Fly Intel: Top five analyst downgrades
04/23/20 BMO Capital
Sysco downgraded to Market Perform from Outperform at BMO Capital
04/06/20 JPMorgan
Sysco price target lowered to $47 from $78 at JPMorgan
03/26/20
Fly Intel: Top five analyst upgrades
GDOT Green Dot
$37.88 /

+0.08 (+0.21%)

05/20/20 Northland
Green Dot price target raised to $42 from $35 at Northland
05/12/20 SunTrust
Green Dot price target raised to $50 from $40 at SunTrust
05/12/20 Craig-Hallum
Green Dot price target raised to $42 from $35 at Craig-Hallum
05/12/20 Needham
Green Dot price target raised to $40 from $30 at Needham
LAZY Lazydays
$6.42 /

+0.44 (+7.36%)

ALRM Alarm.com
$48.73 /

+2.39 (+5.16%)

05/06/20 Raymond James
Alarm.com price target lowered to $55 from $65 at Raymond James
01/27/20 Imperial Capital
Alarm.com upgraded to Outperform from In-Line at Imperial Capital
12/01/19 First Analysis
First Analysis reiterates Strong Buy on Alarm.com after meeting management
10/21/19 First Analysis
Alarm.com upgraded to Strong Buy from Outperform at First Analysis
AMK AssetMark Financial
$25.40 /

-1.3 (-4.87%)

04/14/20 Raymond James
AssetMark Financial price target lowered to $26 from $29 at Raymond James
03/13/20 Raymond James
AssetMark Financial price target lowered to $29 from $33 at Raymond James
01/16/20 Raymond James
AssetMark Financial price target raised to $34 from $32 at Raymond James
12/13/19 JPMorgan
JPMorgan upgrades AssetMark on better than peer asset growth
AMZN Amazon.com
$2,435.18 /

-0.72 (-0.03%)

05/18/20 Bernstein
Amazon not building standalone overnight network, says Bernstein
05/14/20 KeyBanc
Farfetch, Nordstrom, Revolve could be impacted by Amazon offering, says KeyBanc
05/12/20 Barrington
Amazon interest in AMC 'not outside the realm of possibility,' says Barrington
05/11/20 B. Riley FBR
Amazon buyout may not appeal to AMC shareholders, says B. Riley FBR
ALLK Allakos
$71.94 /

-4.84 (-6.30%)

03/25/20 Jefferies
Allakos starts two pivotals on time despite skepticism, says Jefferies
03/12/20 SMBC Nikko
Allakos initiated with an Underperform at SMBC Nikko
02/27/20 Barclays
Allakos initiated with an Underweight at Barclays
02/27/20 Barclays
Allakos initiated with an Underweight at Barclays
PLAN Anaplan
$47.73 /

-3.34 (-6.54%)

05/26/20 Rosenblatt
Rosenblatt says Anaplan reliance on large projects 'clearly impacting' business
05/21/20 RBC Capital
Anaplan price target raised to $55 from $51 at RBC Capital
05/20/20 Mizuho
Mizuho boosts Anaplan target to $50, makes top pick into Software earnings
05/20/20 Wells Fargo
Wells Fargo downgrades Anaplan on 'more difficult near-term setup'
SYY Sysco
$55.12 /

+3.35 (+6.47%)

PLAN Anaplan
$47.73 /

-3.34 (-6.54%)

GDOT Green Dot
$37.88 /

+0.08 (+0.21%)

ARNC Arconic
$13.30 /

+0.41 (+3.18%)

AMZN Amazon.com
$2,435.18 /

-0.72 (-0.03%)

AMK AssetMark Financial
$25.40 /

-1.3 (-4.87%)

ALRM Alarm.com
$48.73 /

+2.39 (+5.16%)

ALLK Allakos
$71.94 /

-4.84 (-6.30%)

SYY Sysco
$55.12 /

+3.35 (+6.47%)

ARNC Arconic
$13.30 /

+0.41 (+3.18%)

AMZN Amazon.com
$2,435.18 /

-0.72 (-0.03%)

ALLK Allakos
$71.94 /

-4.84 (-6.30%)

SYY Sysco
$55.12 /

+3.35 (+6.47%)

PLAN Anaplan
$47.73 /

-3.34 (-6.54%)

GDOT Green Dot
$37.88 /

+0.08 (+0.21%)

ARNC Arconic
$13.30 /

+0.41 (+3.18%)

AMZN Amazon.com
$2,435.18 /

-0.72 (-0.03%)

ALRM Alarm.com
$48.73 /

+2.39 (+5.16%)

ALLK Allakos
$71.94 /

-4.84 (-6.30%)

SYY Sysco
$55.12 /

+3.35 (+6.47%)

PLAN Anaplan
$47.73 /

-3.34 (-6.54%)

ARNC Arconic
$13.30 /

+0.41 (+3.18%)

AMZN Amazon.com
$2,435.18 /

-0.72 (-0.03%)

AMZN Amazon.com
$2,435.18 /

-0.72 (-0.03%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.